1)  RARα
RARα
1.
Construction of Fas/RARα fusion gene expression vector in retinoic acid depende nt manner;
视黄酸可控的Fas/RARα融合基因表达载体构建
2.
Relationship Between AP-1 Activity and RARα Involvement in Gastric Cancer Cells;
胃癌细胞中AP-1活性与RARα介导的相关性
3.
Objective:To evaluate the role of the retinoic acid receptor α(RARα),retinoic acid receptor β(RARβ) in the devel-opment and prognosis of the endometrial carcinoma by detecting the expression of these receptors.
目的:通过检测子宫内膜癌组织中维甲酸受体α(Retinoic acid receptor α,RARα)及维甲酸受体β(Retinoic acidreceptor β,RARβ)表达情况,探讨维甲酸受体在子宫内膜癌发生发展及预后中的作用。
2)  PLZF-RARα/RARα-PLZF
PLZF-RARα/RARα-PLZF
3)  RARα mRNA
RARα mRNA
1.
EXPRESSION OF RARα mRNA AND RARβ mRNA IN THE DEVELOPMENT OF NEURAL TUBE DEFECTS INDUCED BY EXCESSIVE RETINOIC ACID;
RARα mRNA和RARβ mRNA在过量RA致神经管畸形发生中的表达
4)  PML/RARα
PML/RARα
1.
Detection of PML/RARα Gene Transcripts in 46 Newly Diagnosed Acute Promyelocytic Leukemia Patients by Real-time Quantitative Reverse-Transcription Polymerase Chain Reaction;
实时定量PCR检测46例初诊急性早幼粒细胞白血病患者PML/RARα mRNA的分子表达
5)  PML-RARα
PML-RARα
1.
The change of thymic nave T cells in BALB/c mice after immunization with PML-RARα-hIL-2 DNA vaccine;
PML-RARα-hIL-2 DNA疫苗免疫BALB／c小鼠后胸腺初始T细胞水平变化
2.
Immune response induced by reconstructed PML-RARα-hIL-2 plasmids in BALB/c mice;
PML-RARα-hIL-2 DNA疫苗诱导BALB／c小鼠的细胞和体液免疫应答
3.
Study on construction and expression of the eukaryotic coexpression plasmid containing PML-RARαgene and human IL-2 gene;
pIRES-PML-RARα-hIL-2重组质粒的构建和表达研究
6)  PML-RARα gene
PML-RARα基因
1.
Aim: To construct a eukaryotic coexpression plasmid containing PML-RARα gene and human GM-CSF(hGM-CSF) gene,which was expected to be used as a modified DNA vaccine for acute promyelocytic leukemia.
目的:构建急性早幼粒细胞白血病(APL)PML-RARα基因与人粒巨噬细胞集落刺激因子(hGM-CSF)基因真核双表达载体,为利用DNA疫苗治疗APL奠定基础。
2.
Objective To construct the PML-RARα gene recombinant plasmid, which is expected to be used as a modified DNA vaccine for acute promyelocytic leukemia.
目的构建PML-RARα基因重组表达质粒,为发展PML-RARα基因疫苗提供实验依据。
参考词条
补充资料：α,α,α,α',α',α'-六氯对二甲苯
分子式：C8H4Cl6
分子量：312.84
CAS号：68-36-0

性质：白色针状或粉末状结晶。熔点108-110℃。溶于二甲苯、石油醚、乙醇、植物油，不溶于水。无味，有特殊臭味，遇光、碱会缓慢分解而呈酸性。

制备方法：以混二甲苯为原料，先用98%硫酸磺化，使间二甲苯生成间二甲苯磺酸盐。从磺化反应物中分离出含邻、对二甲苯的油层，水洗、干燥，减压蒸馏出邻、对二甲苯。间二甲苯磺酸盐经水解可得副产品间二甲苯。由邻、对二甲苯经氯化即得1，4-双（三氯甲基）苯：在反应锅中投入邻、对二甲苯，再加入过氧化苯甲酰和三乙醇胺。加热到70℃后，在光照射下导入氯气，于70-80℃反应6h，再升温至100-120℃继续反应，至反应液相对密度达到1.560-1.580（65℃），即为反应终点，停止通氯，减压脱除余氯。降温至5℃，过滤，洗涤得粗品，重结晶，活性炭脱色得成品。

用途：抗血吸虫病药物。对肝吸虫病、阿米巴原虫病、疟疾以及肠道线虫有一定疗效。但对神经系统的不良反应较多见，且延迟反应持续较久。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。